| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 7.62e-05 | 28 | 59 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | transporter activity | SFXN1 SLC12A6 ABCA3 ATP8A1 SLC12A4 SLC6A16 SLC34A1 ABCA12 KCNG1 ATG2B TMEM37 PEX2 TMEM266 | 7.90e-05 | 1289 | 59 | 13 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SFXN1 SLC12A6 ABCA3 ATP8A1 SLC12A4 SLC6A16 SLC34A1 ABCA12 KCNG1 TMEM37 PEX2 TMEM266 | 1.45e-04 | 1180 | 59 | 12 | GO:0022857 |
| GeneOntologyMolecularFunction | transcription regulator inhibitor activity | 1.63e-04 | 36 | 59 | 3 | GO:0140416 | |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 3.05e-04 | 9 | 59 | 2 | GO:0015379 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 4.61e-04 | 51 | 59 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 4.96e-04 | 477 | 59 | 7 | GO:0022804 | |
| GeneOntologyMolecularFunction | ammonium channel activity | 5.56e-04 | 12 | 59 | 2 | GO:0008519 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water | 6.56e-04 | 13 | 59 | 2 | GO:0016717 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 7.63e-04 | 14 | 59 | 2 | GO:0140333 | |
| GeneOntologyMolecularFunction | symporter activity | 1.01e-03 | 150 | 59 | 4 | GO:0015293 | |
| GeneOntologyMolecularFunction | flippase activity | 1.13e-03 | 17 | 59 | 2 | GO:0140327 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.27e-03 | 18 | 59 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 2.09e-03 | 23 | 59 | 2 | GO:0015377 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 2.21e-03 | 793 | 59 | 8 | GO:0015075 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 2.67e-03 | 26 | 59 | 2 | GO:0015296 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 2.69e-03 | 196 | 59 | 4 | GO:0005319 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.09e-03 | 28 | 59 | 2 | GO:0051959 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 4.12e-03 | 109 | 59 | 3 | GO:0042626 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 4.74e-03 | 532 | 59 | 6 | GO:0016755 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 5.26e-03 | 119 | 59 | 3 | GO:0015294 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 5.35e-03 | 37 | 59 | 2 | GO:0045505 | |
| GeneOntologyCellularComponent | lamellar body membrane | 4.84e-05 | 4 | 60 | 2 | GO:0097232 | |
| GeneOntologyCellularComponent | TRAPPII protein complex | 5.25e-04 | 12 | 60 | 2 | GO:1990071 | |
| GeneOntologyCellularComponent | TRAPPIII protein complex | 5.25e-04 | 12 | 60 | 2 | GO:1990072 | |
| GeneOntologyCellularComponent | endoplasmic reticulum-Golgi intermediate compartment | 7.22e-04 | 141 | 60 | 4 | GO:0005793 | |
| GeneOntologyCellularComponent | TRAPP complex | 1.07e-03 | 17 | 60 | 2 | GO:0030008 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | CLN8 ESYT3 GORASP2 FADS3 CNEP1R1 OR51M1 ATG2B FADS2 TRAPPC2B TRAPPC2 DUOXA2 | 1.25e-03 | 1327 | 60 | 11 | GO:0042175 |
| GeneOntologyCellularComponent | transport vesicle membrane | 1.52e-03 | 293 | 60 | 5 | GO:0030658 | |
| GeneOntologyCellularComponent | lamellar body | 1.64e-03 | 21 | 60 | 2 | GO:0042599 | |
| Domain | KCC1 | 9.15e-06 | 2 | 57 | 2 | IPR000622 | |
| Domain | Fatty_acid_desaturase | 2.74e-05 | 3 | 57 | 2 | IPR012171 | |
| Domain | KCL_cotranspt | 5.47e-05 | 4 | 57 | 2 | IPR000076 | |
| Domain | SLC12A_fam | 1.90e-04 | 7 | 57 | 2 | IPR004842 | |
| Domain | FA_desaturase_dom | 2.53e-04 | 8 | 57 | 2 | IPR005804 | |
| Domain | FA_desaturase | 2.53e-04 | 8 | 57 | 2 | PF00487 | |
| Domain | SLC12_C | 2.53e-04 | 8 | 57 | 2 | IPR018491 | |
| Domain | DHC_N1 | 2.53e-04 | 8 | 57 | 2 | PF08385 | |
| Domain | SLC12 | 2.53e-04 | 8 | 57 | 2 | PF03522 | |
| Domain | Dynein_heavy_dom-1 | 2.53e-04 | 8 | 57 | 2 | IPR013594 | |
| Domain | ABC_A | 5.92e-04 | 12 | 57 | 2 | IPR026082 | |
| Domain | Roc | 6.99e-04 | 13 | 57 | 2 | PF08477 | |
| Domain | MIRO-like | 6.99e-04 | 13 | 57 | 2 | IPR013684 | |
| Domain | CYTOCHROME_B5_2 | 6.99e-04 | 13 | 57 | 2 | PS50255 | |
| Domain | CYTOCHROME_B5_1 | 6.99e-04 | 13 | 57 | 2 | PS00191 | |
| Domain | Dynein_heavy_chain_D4_dom | 8.13e-04 | 14 | 57 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 8.13e-04 | 14 | 57 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 8.13e-04 | 14 | 57 | 2 | IPR013602 | |
| Domain | DHC_N2 | 8.13e-04 | 14 | 57 | 2 | PF08393 | |
| Domain | MT | 8.13e-04 | 14 | 57 | 2 | PF12777 | |
| Domain | AAA_8 | 8.13e-04 | 14 | 57 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 8.13e-04 | 14 | 57 | 2 | IPR011704 | |
| Domain | Cyt-b5 | 8.13e-04 | 14 | 57 | 2 | PF00173 | |
| Domain | Cyt_B5-like_heme/steroid-bd | 8.13e-04 | 14 | 57 | 2 | IPR001199 | |
| Domain | Cyt-b5 | 8.13e-04 | 14 | 57 | 2 | SM01117 | |
| Domain | - | 8.13e-04 | 14 | 57 | 2 | 3.10.120.10 | |
| Domain | AAA_5 | 8.13e-04 | 14 | 57 | 2 | PF07728 | |
| Domain | DHC_fam | 9.37e-04 | 15 | 57 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 9.37e-04 | 15 | 57 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 9.37e-04 | 15 | 57 | 2 | PF03028 | |
| Domain | AAA+_ATPase | 9.75e-04 | 144 | 57 | 4 | IPR003593 | |
| Domain | AAA | 9.75e-04 | 144 | 57 | 4 | SM00382 | |
| Domain | AA-permease/SLC12A_dom | 2.03e-03 | 22 | 57 | 2 | IPR004841 | |
| Domain | AA_permease | 2.03e-03 | 22 | 57 | 2 | PF00324 | |
| Domain | ArfGap | 3.52e-03 | 29 | 57 | 2 | SM00105 | |
| Domain | ArfGap | 3.52e-03 | 29 | 57 | 2 | PF01412 | |
| Domain | ARFGAP | 3.52e-03 | 29 | 57 | 2 | PS50115 | |
| Domain | ArfGAP | 3.52e-03 | 29 | 57 | 2 | IPR001164 | |
| Domain | ARM-type_fold | 3.70e-03 | 339 | 57 | 5 | IPR016024 | |
| Domain | ABC_transporter_CS | 7.29e-03 | 42 | 57 | 2 | IPR017871 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 2.07e-04 | 7 | 45 | 2 | M27339 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 2.07e-04 | 7 | 45 | 2 | MM15081 | |
| Pubmed | SLC12A6 GORASP2 SLC12A4 ATG2B FADS2 LYST DMXL1 SEMA4C TRAPPC2 | 2.01e-07 | 504 | 60 | 9 | 34432599 | |
| Pubmed | Phosphodiesterase 2A2 regulates mitochondria clearance through Parkin-dependent mitophagy. | 1.14e-06 | 106 | 60 | 5 | 33087821 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 17510708 | ||
| Pubmed | Phospho-regulation, nucleotide binding and ion access control in potassium-chloride cotransporters. | 2.93e-06 | 2 | 60 | 2 | 34031912 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 28237083 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 11718899 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 14597397 | ||
| Pubmed | Identification of the gene (SEDL) causing X-linked spondyloepiphyseal dysplasia tarda. | 2.93e-06 | 2 | 60 | 2 | 10431248 | |
| Pubmed | Genetic disruption of KCC cotransporters in a mouse model of thalassemia intermedia. | 2.93e-06 | 2 | 60 | 2 | 31835175 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 12939648 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 31352162 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 10860662 | ||
| Pubmed | Placental expression of Fatty Acid Desaturases 1, 2 and 3 in selected pregnancy pathologies. | 8.77e-06 | 3 | 60 | 2 | 36652541 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 27269715 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 11551954 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 15262997 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 22877655 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 21040914 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 24985009 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 35274823 | ||
| Pubmed | K-Cl cotransporter gene expression during human and murine erythroid differentiation. | 8.77e-06 | 3 | 60 | 2 | 21733850 | |
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 11134351 | ||
| Pubmed | Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study. | 1.75e-05 | 4 | 60 | 2 | 19148276 | |
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 20562440 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 12637262 | ||
| Pubmed | 2.88e-05 | 1168 | 60 | 10 | 19946888 | ||
| Pubmed | ABC gene expression profiles have clinical importance and possibly form a new hallmark of cancer. | 2.92e-05 | 5 | 60 | 2 | 28468577 | |
| Pubmed | 4.37e-05 | 6 | 60 | 2 | 5367369 | ||
| Pubmed | Functional organization of the yeast proteome by systematic analysis of protein complexes. | 6.11e-05 | 7 | 60 | 2 | 11805826 | |
| Pubmed | 6.11e-05 | 7 | 60 | 2 | 31178125 | ||
| Pubmed | 6.11e-05 | 7 | 60 | 2 | 9256245 | ||
| Pubmed | Bridging expressed sequence alignments through targeted cDNA sequencing. | 8.14e-05 | 8 | 60 | 2 | 15028280 | |
| Pubmed | Gene structure and expression study of the SEDL gene for spondyloepiphyseal dysplasia tarda. | 8.14e-05 | 8 | 60 | 2 | 11031107 | |
| Pubmed | Similar effects of all WNK3 variants on SLC12 cotransporters. | 8.14e-05 | 8 | 60 | 2 | 21613606 | |
| Pubmed | 8.14e-05 | 8 | 60 | 2 | 11395011 | ||
| Pubmed | The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters. | 8.14e-05 | 8 | 60 | 2 | 24393035 | |
| Pubmed | 8.14e-05 | 8 | 60 | 2 | 24293640 | ||
| Pubmed | 8.14e-05 | 8 | 60 | 2 | 12386165 | ||
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 1.05e-04 | 9 | 60 | 2 | 12640130 | |
| Pubmed | 1.05e-04 | 9 | 60 | 2 | 25194280 | ||
| Pubmed | 1.05e-04 | 9 | 60 | 2 | 19323993 | ||
| Pubmed | 1.91e-04 | 12 | 60 | 2 | 27782176 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 2.06e-04 | 704 | 60 | 7 | 29955894 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 2.07e-04 | 942 | 60 | 8 | 31073040 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | 2.34e-04 | 719 | 60 | 7 | 35337019 | |
| Pubmed | 2.57e-04 | 730 | 60 | 7 | 34857952 | ||
| Pubmed | 2.63e-04 | 14 | 60 | 2 | 11472062 | ||
| Pubmed | 2.63e-04 | 14 | 60 | 2 | 23378610 | ||
| Pubmed | 2.63e-04 | 14 | 60 | 2 | 9373155 | ||
| Pubmed | 3.03e-04 | 15 | 60 | 2 | 27066478 | ||
| Pubmed | Cooperation of the NEIL3 and Fanconi anemia/BRCA pathways in interstrand crosslink repair. | 3.46e-04 | 16 | 60 | 2 | 31980815 | |
| Pubmed | 3.54e-04 | 1293 | 60 | 9 | 15342556 | ||
| Pubmed | Loss-of-Function Variants in TBC1D32 Underlie Syndromic Hypopituitarism. | 3.78e-04 | 81 | 60 | 3 | 32060556 | |
| Pubmed | Rare independent mutations in renal salt handling genes contribute to blood pressure variation. | 6.61e-04 | 22 | 60 | 2 | 18391953 | |
| Pubmed | Next-generation sequencing to generate interactome datasets. | 7.64e-04 | 1147 | 60 | 8 | 21516116 | |
| Pubmed | 8.07e-04 | 105 | 60 | 3 | 9628581 | ||
| Pubmed | 8.76e-04 | 108 | 60 | 3 | 22082156 | ||
| Pubmed | 9.24e-04 | 110 | 60 | 3 | 14667819 | ||
| Pubmed | TRAIP regulates replication fork recovery and progression via PCNA. | 9.99e-04 | 27 | 60 | 2 | 27462463 | |
| Pubmed | GORASP2 CNEP1R1 TMEM266 EIF3K HEATR1 TAF2 TSPYL1 AGAP3 SEMA4C | 1.01e-03 | 1497 | 60 | 9 | 31527615 | |
| Pubmed | 1.15e-03 | 29 | 60 | 2 | 21829377 | ||
| Pubmed | 1.15e-03 | 29 | 60 | 2 | 20972250 | ||
| Pubmed | 1.23e-03 | 952 | 60 | 7 | 38569033 | ||
| Pubmed | 1.24e-03 | 464 | 60 | 5 | 32457219 | ||
| Pubmed | 1.32e-03 | 31 | 60 | 2 | 23142642 | ||
| Pubmed | 1.40e-03 | 127 | 60 | 3 | 30442766 | ||
| Pubmed | 1.49e-03 | 33 | 60 | 2 | 22703881 | ||
| Pubmed | Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. | 1.58e-03 | 34 | 60 | 2 | 19060911 | |
| Interaction | DPM2 interactions | 1.64e-05 | 54 | 57 | 4 | int:DPM2 | |
| Interaction | PDE2A interactions | 2.25e-05 | 120 | 57 | 5 | int:PDE2A | |
| Interaction | RAB7A interactions | SFXN1 FANCD2 SLC12A6 GORASP2 SLC12A4 ATG2B FADS2 LYST DMXL1 SEMA4C TRAPPC2 | 3.22e-05 | 886 | 57 | 11 | int:RAB7A |
| Interaction | TMEM30A interactions | 3.56e-05 | 132 | 57 | 5 | int:TMEM30A | |
| Interaction | CTSW interactions | 4.70e-05 | 4 | 57 | 2 | int:CTSW | |
| GeneFamily | Fatty acid desaturases | 1.39e-04 | 8 | 41 | 2 | 553 | |
| GeneFamily | ATP binding cassette subfamily A | 4.49e-04 | 14 | 41 | 2 | 805 | |
| GeneFamily | Dyneins, axonemal | 6.68e-04 | 17 | 41 | 2 | 536 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 6.68e-04 | 17 | 41 | 2 | 1291 | |
| GeneFamily | ArfGAPs | 2.53e-03 | 33 | 41 | 2 | 395 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.08e-06 | 177 | 60 | 5 | 36b5d29caa9cffbc0284f771a4db71aa72171a89 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.43e-06 | 180 | 60 | 5 | a682a5d55c612709c9ee9fa4289d6f8bef7fe1af | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-05 | 111 | 60 | 4 | dfbdeadad321392d359e6fb7112b28b043a4b874 | |
| ToppCell | LPS_only-Lymphocytic_NKT-T_cells-iNKT-MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-05 | 124 | 60 | 4 | 05e114fcfe84cfc8d92978a4eda6db4d8a616e0e | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.69e-05 | 155 | 60 | 4 | 9cad73d0b8ead289e1073d1a2e00bbeb1228308c | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 157 | 60 | 4 | 0673c7161c25feceee8f1e5fd237171576c42c6b | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 157 | 60 | 4 | d307d0b48af35e0e1af41ecd3ebf91be8fd29dc0 | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 157 | 60 | 4 | a84377028c661f8f3ecae0f6082abdd859faf0c8 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-05 | 160 | 60 | 4 | 8a7a73b0ee1877fe02d47f745d36ae2858b529e1 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.08e-05 | 164 | 60 | 4 | 2957065d7f1332c5280d47be7cc342286f84be3e | |
| ToppCell | 390C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 7.08e-05 | 164 | 60 | 4 | 82e57d618c6e59bca4a03d31caf35b6043dfcf52 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.59e-05 | 167 | 60 | 4 | 99db8871c62336bd215efb65e969783d2b6003b0 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.95e-05 | 169 | 60 | 4 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.95e-05 | 169 | 60 | 4 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.32e-05 | 171 | 60 | 4 | ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6 | |
| ToppCell | facs-Marrow-Granulocytes|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.32e-05 | 171 | 60 | 4 | 1701dedf0c18751db6c9fee3d93fff150ed0e17f | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.32e-05 | 171 | 60 | 4 | 4e856441063e9825b6f87a1d3dd19c77dae4662c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.32e-05 | 171 | 60 | 4 | 97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3 | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.51e-05 | 172 | 60 | 4 | c477008444d2d71071177807870d7455e90c2fad | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.10e-05 | 175 | 60 | 4 | 334fad1a147de6c007cec5089c02c35cf3220f1b | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-2|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 9.30e-05 | 176 | 60 | 4 | 1870860a9ebe7a655c4ea8898427e1097ee23113 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.51e-05 | 177 | 60 | 4 | 065bebd22031f143e90a407f952b444a3f8818c7 | |
| ToppCell | facs-Marrow-Granulocytes-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.51e-05 | 177 | 60 | 4 | eb304f20aab075bd17aa3aef819386c0e1a235bd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 180 | 60 | 4 | c62417f205bcbf3b212ae177f63562ec6467c855 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 180 | 60 | 4 | bb2dbf7ed03d5ac765635b7afe738efa822841d0 | |
| ToppCell | COVID-19-kidney-NK|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.04e-04 | 181 | 60 | 4 | 8906ee8a7a1616dfe8c3b5c73988416641213629 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 183 | 60 | 4 | facd6dbe0851b537d70a899ac7485714ab27d071 | |
| ToppCell | CV-Severe-3|CV / Virus stimulation, Condition and Cluster | 1.10e-04 | 184 | 60 | 4 | 1c9bda00bb6efd98f68781ca06655bf6c4282f27 | |
| ToppCell | Control-CD8+_T_activated|Control / Disease group and Cell class | 1.10e-04 | 184 | 60 | 4 | b86cc48b744b3206880ec1373fe6068e14bf9680 | |
| ToppCell | CV-Severe-3|Severe / Virus stimulation, Condition and Cluster | 1.17e-04 | 187 | 60 | 4 | 68cb43a73945f5e252530da25613f6b3f484b4d5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 187 | 60 | 4 | f1356273bd3587b6883295edf15cb9cdb706c057 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 187 | 60 | 4 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 | |
| ToppCell | COVID-19-kidney-NK|kidney / Disease (COVID-19 only), tissue and cell type | 1.25e-04 | 190 | 60 | 4 | e3ca3c9fb9e27670a5dd128dd6564ff98a57159e | |
| ToppCell | Severe-Lymphoid-T-NK|Severe / Condition, Lineage, Cell class and cell subclass | 1.25e-04 | 190 | 60 | 4 | 60642de433f84fa2cecd796c3a1a4aab9219d3db | |
| ToppCell | Epithelial|World / shred on cell class and cell subclass (v4) | 1.30e-04 | 192 | 60 | 4 | 13a3553d9a7c78535679d23d454c63fd08f7d218 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-04 | 193 | 60 | 4 | 5dfa69a680a0859900141c40a446d217aaa747d3 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-04 | 193 | 60 | 4 | ebea35704ac5d21e947ae094313cf2a5205e7014 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|bone_marrow / Manually curated celltypes from each tissue | 1.33e-04 | 193 | 60 | 4 | 1788f865fc9f9a235dbfaf363ed1985fdc715394 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo|bone_marrow / Manually curated celltypes from each tissue | 1.35e-04 | 194 | 60 | 4 | afbf3cecffa2c5e830ebca5db950528cc78fd269 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.35e-04 | 194 | 60 | 4 | e2d0dfb92356fa7ad7008aa8ac4198e2ac5d2495 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-04 | 195 | 60 | 4 | d9694db6bf239636d1335016878c98f6ee2eb0eb | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.41e-04 | 196 | 60 | 4 | ad193b231ff2f7c72590fab79919c179d5d2f327 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Trm_Tgd|GI_small-bowel / Manually curated celltypes from each tissue | 1.41e-04 | 196 | 60 | 4 | 5755ca4abcae3717894bbf7cbd49bca0a3a03067 | |
| ToppCell | ILEUM-non-inflamed-(6)_ILC-(6)_ILC1|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.41e-04 | 196 | 60 | 4 | 8a3a63129adfbe58558af91336f81d397c291ed0 | |
| ToppCell | ILEUM-inflamed-(6)_ILC-(6)_ILC1|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.41e-04 | 196 | 60 | 4 | c1d84d2e4ecc83134c3c694bed3cf035bd2742af | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo|GI_small-bowel / Manually curated celltypes from each tissue | 1.41e-04 | 196 | 60 | 4 | 181f3c1af565355b29f20ca6074147c313ca3477 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.44e-04 | 197 | 60 | 4 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.44e-04 | 197 | 60 | 4 | 8dd10962b6ba587512b2e68c762ade68c751cbc8 | |
| ToppCell | Transverse-T_cell-cycling_gd_T|Transverse / Region, Cell class and subclass | 1.46e-04 | 198 | 60 | 4 | 5131b0b7d6c4dd8872cef9f2e233f59f751b4690 | |
| ToppCell | Transverse-(1)_T_cell-(18)_cycling_gd_T|Transverse / shred on region, Cell_type, and subtype | 1.46e-04 | 198 | 60 | 4 | 396dddf7ebad41c3a91329b6a280623c0dfdcd2f | |
| ToppCell | Transverse-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 1.49e-04 | 199 | 60 | 4 | 7cfe9b2538ea008d67343f3e8bfec3bf81200de6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.49e-04 | 199 | 60 | 4 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Caecum-T_cell-gd_T|T_cell / Region, Cell class and subclass | 1.52e-04 | 200 | 60 | 4 | 564117144a3059017a07d66f718b9b5a1f18265b | |
| Drug | 2-methylisoborneol | 5.45e-07 | 7 | 58 | 3 | CID000016913 | |
| Disease | X-linked spondyloepiphyseal dysplasia tarda (implicated_via_orthology) | 3.80e-06 | 2 | 58 | 2 | DOID:0080362 (implicated_via_orthology) | |
| Disease | spondyloepiphyseal dysplasia congenita (implicated_via_orthology) | 5.67e-05 | 6 | 58 | 2 | DOID:14789 (implicated_via_orthology) | |
| Disease | level of Phosphatidylcholine (16:0_18:0) in blood serum | 5.67e-05 | 6 | 58 | 2 | OBA_2045069 | |
| Disease | level of Phosphatidylcholine (16:1_20:4) in blood serum | 5.67e-05 | 6 | 58 | 2 | OBA_2045084 | |
| Disease | level of Phosphatidylcholine (O-18:2_18:1) in blood serum | 7.92e-05 | 7 | 58 | 2 | OBA_2045133 | |
| Disease | lysophosphatidylcholine 22:4 measurement | 7.92e-05 | 7 | 58 | 2 | EFO_0021461 | |
| Disease | phosphatidylcholine 35:5 measurement | 7.92e-05 | 7 | 58 | 2 | EFO_0021472 | |
| Disease | cholesteryl ester 20:5 measurement | 9.01e-05 | 44 | 58 | 3 | EFO_0010349 | |
| Disease | level of Phosphatidylethanolamine (O-18:1_18:2) in blood serum | 1.06e-04 | 8 | 58 | 2 | OBA_2045147 | |
| Disease | phosphatidylcholine 39:5 measurement | 1.35e-04 | 9 | 58 | 2 | EFO_0021476 | |
| Disease | level of Phosphatidylcholine (18:2_20:1) in blood serum | 1.35e-04 | 9 | 58 | 2 | OBA_2045107 | |
| Disease | level of Phosphatidylcholine (O-18:0_20:4) in blood serum | 1.35e-04 | 9 | 58 | 2 | OBA_2045127 | |
| Disease | level of Phosphatidylcholine (O-18:1_18:2) in blood serum | 1.35e-04 | 9 | 58 | 2 | OBA_2045129 | |
| Disease | level of Phosphatidylcholine (O-18:1_20:3) in blood serum | 1.35e-04 | 9 | 58 | 2 | OBA_2045130 | |
| Disease | level of Phosphatidylcholine (16:0_20:5) in blood serum | 1.35e-04 | 9 | 58 | 2 | OBA_2045077 | |
| Disease | level of Phosphatidylcholine (18:0_20:5) in blood serum | 1.35e-04 | 9 | 58 | 2 | OBA_2045095 | |
| Disease | level of Phosphatidylethanolamine (O-18:1_20:4) in blood serum | 1.69e-04 | 10 | 58 | 2 | OBA_2045148 | |
| Disease | cholesteryl ester 22:4 measurement | 1.69e-04 | 10 | 58 | 2 | EFO_0021443 | |
| Disease | cholesteryl ester 22:5 measurement | 1.69e-04 | 10 | 58 | 2 | EFO_0021444 | |
| Disease | level of Phosphatidylcholine (O-16:1_20:4) in blood serum | 2.06e-04 | 11 | 58 | 2 | OBA_2045123 | |
| Disease | lysophosphatidylcholine 20:2 measurement | 2.06e-04 | 11 | 58 | 2 | EFO_0021458 | |
| Disease | cholesteryl ester 20:2 measurement | 2.47e-04 | 12 | 58 | 2 | EFO_0021440 | |
| Disease | inflammatory bowel disease | 2.49e-04 | 449 | 58 | 6 | EFO_0003767 | |
| Disease | level of Phosphatidylcholine (O-16:0_20:4) in blood serum | 2.92e-04 | 13 | 58 | 2 | OBA_2045116 | |
| Disease | level of Phosphatidylcholine (16:0_18:3) in blood serum | 2.92e-04 | 13 | 58 | 2 | OBA_2045072 | |
| Disease | level of Phosphatidylcholine (18:1_20:2) in blood serum | 3.40e-04 | 14 | 58 | 2 | OBA_2045102 | |
| Disease | diacylglycerol 38:4 measurement | 3.40e-04 | 14 | 58 | 2 | EFO_0020066 | |
| Disease | level of Phosphatidylcholine (O-18:1_20:4) in blood serum | 3.92e-04 | 15 | 58 | 2 | OBA_2045131 | |
| Disease | cis/trans-18:2 fatty acid measurement, trans fatty acid measurement | 3.92e-04 | 15 | 58 | 2 | EFO_0006821, EFO_0006824 | |
| Disease | oleoyl-arachidonoyl-glycerol (18:1/20:4) [2] measurement | 3.92e-04 | 15 | 58 | 2 | EFO_0800508 | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 3.92e-04 | 15 | 58 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | vitamin C measurement | 4.48e-04 | 16 | 58 | 2 | EFO_0600003 | |
| Disease | total iron binding capacity | 4.94e-04 | 78 | 58 | 3 | EFO_0006334 | |
| Disease | phosphatidylcholine 36:4 measurement | 5.69e-04 | 18 | 58 | 2 | EFO_0010382 | |
| Disease | level of Phosphatidylcholine (20:4_0:0) in blood serum | 5.69e-04 | 18 | 58 | 2 | OBA_2045110 | |
| Disease | level of Phosphatidylcholine (16:0_22:5) in blood serum | 5.69e-04 | 18 | 58 | 2 | OBA_2045079 | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 6.36e-04 | 19 | 58 | 2 | OBA_2045199 | |
| Disease | diacylglycerol 38:5 measurement | 6.36e-04 | 19 | 58 | 2 | EFO_0020067 | |
| Disease | diacylglycerol 38:3 measurement | 6.36e-04 | 19 | 58 | 2 | EFO_0020065 | |
| Disease | brain age measurement | 7.05e-04 | 20 | 58 | 2 | EFO_0010602 | |
| Disease | level of Phosphatidylcholine (18:1_20:4) in blood serum | 7.78e-04 | 21 | 58 | 2 | OBA_2045104 | |
| Disease | level of Phosphatidylinositol (18:0_18:2) in blood serum | 7.78e-04 | 21 | 58 | 2 | OBA_2045156 | |
| Disease | level of Phosphatidylcholine (16:0_20:4) in blood serum | 7.78e-04 | 21 | 58 | 2 | OBA_2045076 | |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 9.36e-04 | 23 | 58 | 2 | OBA_2045158 | |
| Disease | phosphatidylserines measurement | 9.36e-04 | 23 | 58 | 2 | EFO_0020049 | |
| Disease | alpha-linolenic acid measurement | 1.11e-03 | 25 | 58 | 2 | EFO_0007759 | |
| Disease | lysophosphatidylethanolamine 18:2 measurement | 1.20e-03 | 26 | 58 | 2 | EFO_0010369 | |
| Disease | level of Phosphatidylcholine (17:0_20:4) in blood serum | 1.20e-03 | 26 | 58 | 2 | OBA_2045087 | |
| Disease | docosapentaenoic acid measurement | 1.29e-03 | 27 | 58 | 2 | EFO_0006809 | |
| Disease | level of Phosphatidylethanolamine (18:0_18:2) in blood serum | 1.39e-03 | 28 | 58 | 2 | OBA_2045139 | |
| Disease | lysophosphatidylethanolamine 20:4 measurement | 1.49e-03 | 29 | 58 | 2 | EFO_0010370 | |
| Disease | eicosapentaenoic acid measurement | 1.70e-03 | 31 | 58 | 2 | EFO_0007760 | |
| Disease | level of Sterol ester (27:1/20:4) in blood serum | 1.70e-03 | 31 | 58 | 2 | OBA_2045198 | |
| Disease | level of Phosphatidylcholine (18:0_20:4) in blood serum | 1.70e-03 | 31 | 58 | 2 | OBA_2045094 | |
| Disease | lysophosphatidylcholine 20:4 measurement | 1.81e-03 | 32 | 58 | 2 | EFO_0010363 | |
| Disease | cholesteryl ester 22:6 measurement | 1.81e-03 | 32 | 58 | 2 | EFO_0010350 | |
| Disease | phosphatidylcholine 38:5 measurement | 1.93e-03 | 33 | 58 | 2 | EFO_0010387 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FEFVVVSLTGQTWHF | 571 | Q96P47 | |
| WSQVFSFFVHNVATE | 511 | A0FGR9 | |
| NSCSHFFAWLIESVG | 1106 | Q86UK0 | |
| FTQTAHSGRCAFWGN | 96 | P22570 | |
| CHTNNTGTSFQWIFN | 166 | Q3KPI0 | |
| QFVSGVHVASFWLSA | 1131 | Q99758 | |
| FEFLIVSSTGQTWHF | 876 | Q99490 | |
| LCFTHFGEQVWQFST | 961 | Q4L235 | |
| FEWGHSQQITCFRSG | 2771 | Q9Y485 | |
| WHFCTTTNQTICFRD | 61 | Q8WXS4 | |
| HGEFWLEFNSGSLFC | 1081 | Q96BY7 | |
| FNTKVFWVHCLNGLF | 936 | Q9Y2Q0 | |
| FSHWNNRVFVGATDS | 146 | Q16769 | |
| WSELVAEFGQFFHAT | 486 | Q8NAB2 | |
| FWNAAFFDAVHCERT | 306 | O60268 | |
| TATCNVEQSFFNDWF | 361 | O95864 | |
| RFCSFDGANENVWHV | 101 | Q9H8Y8 | |
| LTNHQLFFVGFAQVW | 741 | P0DPD6 | |
| IFWFNSHSIYFGACQ | 96 | Q9H341 | |
| QLVWSQFTQCFHGFK | 31 | P28328 | |
| HNVFIVESVCVGWFS | 266 | Q9UIX4 | |
| AWFGVLSCVQAEFFT | 11 | O15460 | |
| AFAGATVHDCFNWLS | 216 | Q06495 | |
| ACLGFFLDQSVWAHV | 11 | Q99706 | |
| ECIFQFTGNFASFCW | 111 | Q7L622 | |
| HFSAEWFVGTVNTNT | 71 | Q1HG44 | |
| HQLFFVGFAQVWCSV | 816 | P0DPD8 | |
| CHGGFVWDAFITVLN | 191 | P56202 | |
| GDLLETCHFQAFWQA | 106 | Q9UBQ5 | |
| EGFSVSLWFNVECIH | 1471 | Q99698 | |
| FRCQFANGIFQLWFH | 736 | Q8WUQ7 | |
| FWFSVCCEFSVQHQI | 1446 | Q9H583 | |
| LFTNWFSGHLNFQIE | 371 | Q9Y5Q0 | |
| FHFDGFEINLVWSCG | 1886 | Q9P225 | |
| WGFFCNSSQFFNATC | 406 | Q9UHW9 | |
| QDLTEAEGWHFFCFQ | 146 | Q96F10 | |
| SQFTSWVFNGRPHCF | 4466 | Q8TE73 | |
| WVGHTICNDFQDAFV | 651 | Q9BXW9 | |
| SNLFVVSSDFCHWGQ | 181 | Q9Y316 | |
| HFEVWCQNTGEVAFL | 446 | Q7L3T8 | |
| FNFCVLGFWATVITH | 391 | Q9GZN6 | |
| WDQSTFIGRANHFFT | 16 | Q9H9B4 | |
| CVYFFWQGRHSTVSE | 1811 | O95425 | |
| GFCFDDTVQWHFCSV | 601 | P12259 | |
| HVFSCGYQNSTRFWF | 176 | Q6P1X5 | |
| TSWHNTTFFGVFQAQ | 306 | Q9C0C4 | |
| FTSLWNHPFFTISCI | 61 | Q8N9A8 | |
| FHTFASEWLNFEFVC | 826 | Q13018 | |
| NETVATQLWSFFCHS | 331 | Q9UP95 | |
| NWCWFHITTATGFFC | 101 | Q9UBY8 | |
| THIVFVDFDNWSNFF | 886 | Q9Y4E5 | |
| SFIAAGICFNIALWH | 126 | Q5BJH2 | |
| QDLICSFFTWFSDHS | 371 | Q9H0U9 | |
| QDSQVHTWGCLFSTF | 241 | Q8N816 | |
| KFNEWFVSAFVTAGH | 66 | P0DI81 | |
| KFNEWFVSAFVTAGH | 66 | P0DI82 | |
| GDCCSFITQLVNHFW | 2616 | Q5T4S7 | |
| LQFSSAFQFAGVIHW | 126 | Q2M3C6 | |
| GHTFHLQCLIQWFET | 26 | Q9BWF2 | |
| IFHDDGVFWVTFSCI | 401 | Q9NS93 |